Why Your Libido Disappeared (And What to Do About It)

You used to think about it. Not constantly, not obsessively, just—it was there. A background hum. A warmth that would show up uninvited while reading a novel, watching someone laugh, feeling the specific weight of another person leaning against you on a couch. And then at some point—you can’t pin the week, let alone the day—it stopped. Not dramatically. Not like a switch. More like a radio station slowly losing signal until all that’s left is static, and then silence, and then you forget the radio was ever on.

And now there’s a gap where desire used to live. Maybe your partner has noticed. Maybe they haven’t said anything, which is almost worse, because the silence around it grows its own gravity. Maybe you’re single and the absence is quieter but no less strange—a disconnection from your own body, from the sensory aliveness that used to be just yours, nobody else’s business.

You’re not broken. You’re not “getting old.” And you’re not alone in this. According to epidemiological data, roughly 30-40% of adults report a significant period of reduced sexual desire at some point. For women, prevalence estimates run even higher. This is one of the most common health concerns that almost nobody talks about honestly, because it touches identity, relationships, self-worth—all the places where clinical language feels thin and inadequate.

So let’s skip the clinical language and talk about what’s actually happening in your body. Because once you understand the machinery, the solutions start making sense.

What’s Actually Happening

Here’s what most “low libido” articles get wrong: they treat it as a single problem with a single cause. It’s not. Desire is an emergent property—the result of hormonal signaling, neurotransmitter balance, nervous system state, sleep architecture, relational safety, and sensory processing all working together. When any of those systems falls out of tune, desire is often the first thing to go quiet. It’s not a luxury your body cuts. It’s a signal your body sends.

The Cortisol Problem

Start here, because this is the one almost everyone is dealing with on some level.

Your body runs on a priority system. When your hypothalamic-pituitary-adrenal axis—the HPA axis, your central stress command—reads the environment as threatening, it redirects resources toward survival. Cortisol rises. And cortisol doesn’t just suppress libido through some vague “stress makes you not want sex” mechanism. It does something more specific and more insidious: cortisol directly suppresses gonadotropin-releasing hormone (GnRH), the upstream signal that tells your body to produce the sex hormones—testosterone, estrogen, progesterone—that drive desire.

Think of it as a resource allocation problem. Cortisol and sex hormones share the same precursor: pregnenolone. When your body is churning out cortisol to handle chronic stress, it literally steals the raw material that would otherwise become testosterone and estrogen. Endocrinologists call this the “pregnenolone steal.” Your body is not confused. It’s making a calculated decision: survive now, reproduce later. The problem is that for most modern humans, the stress never actually resolves. The tiger never leaves. So “later” becomes “never.”

Hormones Beyond Stress

Testosterone matters for libido in every body, not just male ones. Women produce testosterone too—less of it, but it’s equally central to desire and arousal. Natural testosterone decline begins in the late twenties for men and follows its own complex pattern in women, especially around perimenopause and menopause, where the hormonal shifts are seismic. Estrogen fluctuations—across the menstrual cycle, during hormonal birth control use, through the menopausal transition—directly affect vaginal tissue health, arousal mechanics, and the neurochemistry of desire.

Hormonal birth control deserves its own mention because it’s so common and so rarely discussed in this context. Combined oral contraceptives increase sex hormone-binding globulin (SHBG), which binds to free testosterone and makes it unavailable. The result, for some women, is a measurable reduction in the testosterone that drives desire. Not every woman on birth control experiences this. But for those who do, the cause of their “lost libido” is sitting in their medicine cabinet, and nobody thought to mention it.

The Sleep Connection

This one is quantified and it’s brutal. A 2011 study by Leproult and Van Cauter, published in JAMA, found that restricting healthy young men to five hours of sleep per night for one week reduced their testosterone levels by 10 to 15 percent. One week. These were men in their twenties—peak hormonal years. The testosterone drop from a single week of short sleep was equivalent to 10 to 15 years of aging.

Let that land. If you’re sleeping six hours a night and wondering where your sex drive went, you may have just found it.

Sleep is when your body does its major hormonal housekeeping. The largest pulse of testosterone release occurs during REM sleep. Cut sleep short, and you cut production short. Chronically. And because testosterone affects desire, energy, mood, and body composition, the downstream effects compound. Worse sleep leads to lower testosterone, which leads to less energy, which leads to worse sleep. The cycle is self-reinforcing until something interrupts it.

The Relationship Dimension

I’m going to be brief here, not because it’s unimportant—it might be the most important factor for many people—but because it’s not the kind of thing that responds well to bullet points.

Desire exists in context. It requires some degree of psychological safety, novelty, and presence. Long-term relationships have a tendency to optimize for security at the expense of the erotic tension that feeds desire—Esther Perel has written about this better than anyone. Unresolved resentment, communication breakdowns, feeling unseen by a partner—these are not small things. They are the soil desire grows in, or doesn’t.

If your relationship dynamics are a significant factor, this article’s supplement recommendations won’t fix that. Talk to each other. Or talk to someone together. That said, the biological factors below are worth addressing regardless, because a well-rested, hormonally balanced, neurochemically alive person will bring more to those conversations than an exhausted, cortisol-flooded one.

Aging—A Factor, Not a Sentence

Yes, hormonal output declines with age. No, this does not mean desire has an expiration date. Research consistently shows that many people maintain active, satisfying sex lives well into their seventies and eighties. What changes is often not capacity but the conditions required—more attention to arousal, more communication, more willingness to adapt. The cultural narrative that aging equals the end of sexuality is not supported by the data. It’s supported by pharmaceutical advertising that wants to sell you a solution to a problem it told you was inevitable.

The SSRI Paradox

This gets its own section because the cruelty of it deserves attention.

SSRIs—selective serotonin reuptake inhibitors, the most commonly prescribed antidepressants in the world—work by increasing serotonin availability in the brain. This helps with depression. It also, in a substantial percentage of users, decimates sexual function. Clayton et al. (2014) reported that 40 to 65 percent of SSRI users experience sexual side effects: reduced desire, difficulty with arousal, delayed or absent orgasm, genital numbness. Forty to sixty-five percent. This is not a rare side effect. This is the majority experience.

The mechanism is well understood. Serotonin, at elevated levels, suppresses dopamine and norepinephrine—the neurotransmitters most associated with motivation, reward, and arousal. It also directly inhibits nitric oxide synthase, reducing genital blood flow. SSRIs are doing exactly what they were designed to do, and the sexual side effects are a direct consequence of that mechanism, not an unfortunate accident.

Here’s where it becomes genuinely painful: the people taking SSRIs are often already struggling. Depression itself suppresses libido. So the person arrives at their doctor’s office having lost interest in sex because of their depression, gets prescribed a medication that further suppresses sexual function, and then—the part nobody warns them about adequately—experiences this as confirmation that something is deeply wrong with them rather than a predictable pharmaceutical side effect. The shame compounds. The silence deepens.

If this is you: the problem is not you. The problem is a medication side effect that your prescriber should have discussed with you in detail before you started the drug.

And here’s the part of this conversation that’s changed in recent years. The traditional SSRI model works by dampening—dampening serotonin reuptake, dampening emotional extremes, and, as collateral damage, dampening the sensory and emotional aliveness that feeds desire. Psilocybin, studied now in serious clinical settings, appears to work through the opposite mechanism. The Imperial College London trial comparing psilocybin to escitalopram found that while antidepressant efficacy was comparable, the psilocybin group showed greater improvements in emotional responsiveness, the ability to feel pleasure, and overall well-being. Not blunting. Enhancement. This is a fundamentally different pharmacological philosophy—one that opens emotional and sensory range rather than narrowing it.

For SSRI-induced sexual dysfunction specifically, Modabbernia et al. (2012) demonstrated that saffron (30mg daily) significantly improved sexual function in women on fluoxetine. The Dording et al. (2015) maca trial showed similar results. These aren’t cures, but they’re real data showing that the SSRI sexual side effect is not a life sentence—it can be mitigated, sometimes substantially, without abandoning the antidepressant.

If you’re on an SSRI and experiencing sexual side effects, talk to your prescriber. Options include dose reduction, switching to bupropion (which has the lowest sexual side effect profile of any major antidepressant), augmentation with the supplements discussed below, or—if appropriate and supervised—exploring whether psilocybin-assisted therapy might address the underlying depression through a mechanism that doesn’t require the trade-off.

What Actually Helps

Not everything marketed for libido has evidence behind it. And not everything with evidence behind it will work for your specific situation. Here’s the honest breakdown, organized by strength of evidence.

Tier One: Address the Root Cause First

This is not the exciting section. It’s the most important one.

Sleep. Seven to nine hours. Consistently. If the Leproult and Van Cauter data doesn’t convince you, nothing in a capsule will compensate for what five-hour nights are doing to your hormonal baseline.

Stress reduction. Not the vague “maybe try yoga” kind. Actual, structural changes to your cortisol load. Meditation has strong evidence for HPA axis regulation. So does time in nature, social connection, and eliminating or reducing the specific stressors that are keeping your nervous system in threat-detection mode.

Exercise. Lorenz and Meston (2014) demonstrated that acute exercise increases genital arousal in women, including women on antidepressants. The effect is both immediate (post-exercise blood flow and sympathetic nervous system activation prime arousal pathways) and cumulative (regular exercise improves body image, cardiovascular health, and testosterone production). Resistance training in particular supports natural testosterone optimization in both men and women.

Medication review. If you started a new medication—SSRI, beta-blocker, hormonal birth control, finasteride, opioid—in the months before your libido changed, that’s a conversation worth having with your doctor. Not to necessarily stop the medication, but to explicitly weigh the sexual side effects against the benefits and explore alternatives.

Nutrient foundations. Zinc deficiency directly impairs testosterone production. Vitamin D deficiency correlates with lower testosterone levels. Magnesium supports hundreds of enzymatic processes, including hormone synthesis. These aren’t exotic interventions. They’re the nutritional floor your endocrine system needs to function.

Tier Two: Strong Botanical Evidence

Maca root. The Gonzales et al. (2002) finding is still one of the most remarkable in this entire field: maca increased sexual desire in men after eight weeks, and the effect was independent of testosterone and estrogen levels. That means maca isn’t just boosting hormones. It’s working through a mechanism we don’t fully understand yet—likely involving the hypothalamic-pituitary axis—that enhances desire directly. For women on SSRIs specifically, the Dording 2015 trial at Massachusetts General Hospital showed significant improvement in sexual function at 3g daily. Among botanical libido interventions, maca has the deepest evidence base. More detail on our maca apothecary page.

Ashwagandha. If cortisol is your primary saboteur—and if you’re reading this article during a stressful period of your life, it probably is—ashwagandha is relevant. The cortisol reduction (up to 28% in clinical trials) directly addresses the pregnenolone steal, freeing up raw material for sex hormone production. Lopresti et al. (2019) specifically found improvements in testosterone and sexual function in men supplementing with ashwagandha. The mechanism is indirect—reduce cortisol, restore hormonal resources—but the downstream effect on desire is real. See the ashwagandha apothecary page for the full evidence review.

Ginseng. De Andrade et al. (2007) reviewed the clinical evidence for Panax ginseng and sexual function, finding meaningful improvements in erectile function and sexual satisfaction. The ginsenosides in ginseng enhance nitric oxide synthesis—the same pathway that Viagra targets, through a gentler mechanism. For women, the evidence is thinner but positive, particularly for arousal in menopausal populations. More at our ginseng apothecary page.

Tribulus terrestris and Fenugreek. Both have positive clinical data for sexual desire—tribulus primarily in women with hypoactive sexual desire disorder, fenugreek through effects on androgen metabolism. The evidence is real but not as deep as maca or ashwagandha. Worth considering as part of a broader approach rather than as standalone solutions.

Tier Three: Promising and Traditional

Psilocybin microdosing—the sensory dimension.

This is where the conversation shifts from “fixing a deficiency” to “expanding a capacity.”

Everything discussed above targets the biological floor—restoring hormones, reducing cortisol, addressing pharmaceutical side effects. Microdosing psilocybin operates on a different level. It doesn’t boost testosterone. It doesn’t modulate cortisol. What it appears to do, based on both clinical observation and extensive user reporting, is enhance the sensory and emotional dimensions of experience that feed desire from the inside.

Kettner et al. (2019), studying psychedelic use and emotional well-being, found that microdosers reported significant improvements in emotional connection, relationship satisfaction, and overall well-being. The improvements weren’t limited to mood—they extended to how people experienced sensory input, social bonding, and intimacy.

The mechanism connects to what psilocybin does at the neural level. At microdose levels, psilocybin acts as a serotonin 2A receptor agonist, promoting subtle increases in neuroplasticity, sensory cross-talk, and default mode network flexibility. In practical terms, this translates to experiences people describe consistently: colors appear more saturated. Music lands differently—not just heard but felt. Textures become more interesting. Food tastes more vivid.

And touch. Touch especially.

This is the part that matters for this conversation. When the sensory volume gets turned up gently—not tripping, not overwhelmed, just more present in your body—the experience of physical intimacy changes. Not because your hormones shifted. Because your capacity to feel what’s already there expanded. The warmth of skin against skin registers more fully. Eye contact carries more weight. The emotional and the physical stop being separate categories and start being the same thing.

This is not the same mechanism as maca or ashwagandha. It’s not fixing something broken. It’s amplifying something dimmed. For people whose libido loss is tangled up with emotional disconnection, numbness, the flattening that comes from chronic stress or SSRIs or just the accumulated dimming of a life lived mostly in your head—the sensory re-engagement that microdosing facilitates can be the piece that makes everything else click.

A caveat: the clinical trial literature specifically on microdosing and sexual function is still emerging. Large placebo-controlled studies are in progress but not yet published. What we have is the Kettner data, consistent user reports, and a neurobiological mechanism (enhanced sensory processing and emotional connectivity) that makes the reported effects plausible. This is promising evidence, not established protocol. Treat it accordingly.

Saffron. For SSRI-induced sexual dysfunction specifically, Modabbernia et al. (2012) demonstrated significant improvements in arousal and lubrication in women on fluoxetine at 30mg daily. Saffron modulates serotonergic and dopaminergic systems, partially counteracting the sexual side effects of SSRIs without undermining their antidepressant action. A targeted intervention for a specific situation.

Ceremonial cacao. Theobromine (a mild vasodilator and stimulant), phenylethylamine (the “love chemical” your brain produces during attraction), and anandamide (an endocannabinoid that promotes feelings of bliss)—cacao delivers all three in natural ratios. Traditional Mesoamerican cultures paired cacao with psilocybin mushrooms for ceremonial purposes, a combination that’s been validated by modern understanding of how these compounds interact. The effect is more subtle than pharmaceutical intervention—a gentle warming, an emotional openness, an enhanced receptivity to pleasure. See the cacao apothecary page for the full breakdown.

Damiana. Turnera diffusa has been used as an aphrodisiac in Central and South American traditional medicine for centuries. Modern research is thin but suggests anxiolytic properties that may reduce the psychological inhibition component of low desire. Considered traditional rather than clinically established.

What’s Overhyped

Most “libido supplement” blends marketed online contain pixie-dusted amounts of ingredients with marginal evidence, packaged in suggestive bottles with pseudoscientific copy. If the label promises “explosive” anything, the only thing it’s going to explode is your trust in supplement marketing.

“Testosterone booster” supplements marketed to men are particularly egregious. Most contain ingredients (DHEA, D-aspartic acid, faded herbs at sub-clinical doses) that either don’t meaningfully raise testosterone in controlled studies or raise it by amounts too small to affect function. If you actually have clinically low testosterone, you need bloodwork and a conversation with an endocrinologist, not a supplement with a bull on the label.

What We’d Actually Tell a Friend

If a friend sat across the table and said I just don’t want it anymore and I don’t know why, here’s what we’d say.

First: that’s one of the most common things a human body does. It’s not a failure. It’s information. Something in the system is asking for attention—maybe your sleep, maybe your stress, maybe a medication side effect nobody warned you about, maybe a relationship conversation you’ve been avoiding. Probably more than one.

Second: start with blood work. Testosterone, estrogen, cortisol, thyroid panel, vitamin D, zinc. Get the data. You can’t troubleshoot what you can’t measure. This step alone resolves the mystery for more people than any supplement ever will.

Third: fix the foundations. Sleep. Cortisol management. Exercise—resistance training especially. These aren’t sexy recommendations. They’re the ones that work.

Fourth: if the foundations are solid and you want to go further, maca root has the best evidence for desire specifically. If stress is the dominant factor, ashwagandha addresses the cortisol pathway directly. If you’re on an SSRI, maca and saffron have clinical data for that specific situation.

Fifth: if what you’re missing isn’t mechanical but experiential—if the issue is less “I can’t” and more “I don’t feel”—that’s where microdosing psilocybin enters the conversation. The sensory enhancement, the emotional openness, the increased presence in your own body. It’s not a libido drug. It’s a way of being more fully in the experience that makes libido meaningful.

And sixth: be patient with yourself. Desire is not a performance metric. It’s a dimension of being alive, and like every other dimension of being alive, it fluctuates. The goal isn’t to optimize it like a quarterly target. The goal is to create the conditions—biological, emotional, relational—where it can show up when it’s ready.

It usually does.